CN114324724A - Method for identifying authenticity of liver essence paste based on thin-layer chromatography - Google Patents
Method for identifying authenticity of liver essence paste based on thin-layer chromatography Download PDFInfo
- Publication number
- CN114324724A CN114324724A CN202111560555.8A CN202111560555A CN114324724A CN 114324724 A CN114324724 A CN 114324724A CN 202111560555 A CN202111560555 A CN 202111560555A CN 114324724 A CN114324724 A CN 114324724A
- Authority
- CN
- China
- Prior art keywords
- liver
- solution
- pork liver
- spots
- thin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 97
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000004809 thin layer chromatography Methods 0.000 title claims abstract description 18
- 235000015277 pork Nutrition 0.000 claims abstract description 68
- 239000000243 solution Substances 0.000 claims abstract description 54
- 229940040511 liver extract Drugs 0.000 claims abstract description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 23
- 239000012085 test solution Substances 0.000 claims abstract description 20
- 238000001035 drying Methods 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000006228 supernatant Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000013558 reference substance Substances 0.000 claims abstract description 9
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 38
- 239000004471 Glycine Substances 0.000 claims description 19
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 17
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims description 17
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 17
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims description 17
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 17
- 235000004279 alanine Nutrition 0.000 claims description 17
- 235000013477 citrulline Nutrition 0.000 claims description 17
- 229960002173 citrulline Drugs 0.000 claims description 17
- 239000000523 sample Substances 0.000 claims description 17
- 239000004474 valine Substances 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 241000212749 Zesius chrysomallus Species 0.000 claims description 8
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 5
- 239000012088 reference solution Substances 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 238000009210 therapy by ultrasound Methods 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 238000007670 refining Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to a method for identifying the authenticity of a liver extract based on thin-layer chromatography, which comprises the following specific steps: preparing a test solution; preparing a pork liver reference medicinal material solution: drying fresh pork liver at low temperature, pulverizing to obtain pork liver powder, adding 1g pork liver powder, adding 4ml water, adding 1 drop of 2% hydrochloric acid, shaking, keeping the temperature at 90-100 deg.C for 40min, centrifuging, collecting supernatant, concentrating to near dryness, adding 4ml ethanol for dissolving, centrifuging again, and collecting supernatant as pork liver control medicinal material solution; preparing a reference substance solution; and (5) detecting by thin layer chromatography. The invention aims to fill the blank of the liver extract identification method, solve or at least reduce the problems of poor specificity and inaccurate result of the existing liver extract identification method, and provide a method for identifying the authenticity of the liver extract based on thin-layer chromatography.
Description
Technical Field
The invention relates to the technical field of liver extract identification, in particular to a method for identifying the authenticity of liver extract based on thin-layer chromatography.
Background
The liver extract is a liver extract prepared by extracting, concentrating and refining livers of animals such as pigs, cattle, sheep and the like. The liver essence ointment prepared by taking pork liver as a raw material is an important intermediate of a medicinal preparation, namely the liver essence hematotonin oral liquid. Pig liver, recorded in Zhonghua Bencao, has the actions of tonifying liver, improving vision, nourishing spleen and strengthening blood. Can be used for treating liver deficiency, blurred vision, and night blindness. Sallow complexion due to blood deficiency, etc. The liver essence paste is extracted and refined from pig liver and other raw materials, and also has the efficacy. In particular, the liver essence paste made from pork liver is the main component of the medicine such as liver essence hematinic oral liquid. The execution standard is the Chinese patent medicine preparation standard in the ministry of health, wherein the preparation method and the quality standard of the liver essence ointment are described more sparsely, and no proper identification method is available for the chemical characteristics of the liver essence ointment in the standard. The quality standards aiming at chemical properties are not collected in the Chinese pharmacopoeia edition and local standards all the year round, and only physical indexes are available, so that the main properties of the Chinese pharmacopoeia edition and the local standards cannot be reflected.
According to the existing literature, the main components in the pork liver are: protein, fat, vitamin A, vitamin D, and vitamin B1Vitamin B2Vitamin B6Vitamin B12Nicotinamide, vitamin C, folic acid, vitamin E, phosphorus, potassium, magnesium, iron, zinc, calcium, selenium and the like. After extraction, concentration and refining, the components of the liver essence paste mainly comprise the above parts, the content of some components is greatly improved, and some components are reduced or even lost.
The current state of quality standard for load collection:
(1) the ministerial standard Chinese medicine prescription preparation, WS3-B-2530-97, in the thirteenth volume, contains liver extract standard, which is a pre-refining process of pork liver extract, and has only examination items and no identification items;
(2) the Jiangsu province drug standard is the liver extract loading standard in 1997 edition, only has inspection items and no identification items;
(3) the national standard of chemical medicine is upgraded to liver extract standard WS-10001- (HD-0812) -2002 in volume 9 of the national standard, and the identification item is chemical identification which is the color reaction of amino acid to ninhydrin and has poor specificity.
In summary, the existing standard is that there is no differentiation item or simple chemical differentiation with poor specificity for liver extract of liver paste animals. The standard can not reflect the due components in the pork liver and can not reflect the quality characteristics of the liver essence paste. Therefore, the existing method has weak specificity and inaccurate result.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, fill the blank of the liver extract identification method, solve or at least alleviate the problems of poor specificity and inaccurate result of the existing liver extract identification method, and provide a method for identifying the authenticity of the liver extract based on thin-layer chromatography.
The invention is realized by the following technical scheme:
a method for identifying the authenticity of liver essence paste based on thin-layer chromatography comprises the following specific steps:
preparation of a test solution: taking 1g of a to-be-detected product, adding 20ml of ethanol, carrying out ultrasonic treatment for 30min, and then filtering, wherein the filtered filtrate is used as a test solution;
preparing a pork liver reference medicinal material solution: drying fresh pork liver at low temperature, pulverizing to obtain pork liver powder, adding 1g pork liver powder, adding 4ml water, adding 1 drop of 2% hydrochloric acid, shaking, keeping the temperature at 90-100 deg.C for 40min, centrifuging, collecting supernatant, concentrating to near dryness, adding 4ml ethanol for dissolving, centrifuging again, and collecting supernatant as pork liver control medicinal material solution;
preparation of control solutions: respectively taking valine, alanine, glycine and citrulline reference substances, and adding methanol to obtain solutions each containing 0.5mg per 1ml as reference substance solutions;
and (3) detection by thin-layer chromatography: sucking 2-4 mul of a test solution, 2-4 mul of a pork liver control medicinal material solution and 2 mul of a control solution respectively, respectively dropping the solutions on the same silica gel G thin layer plate, developing by using n-butyl alcohol-glacial acetic acid-water as a developing agent, taking out the silica gel G thin layer plate, drying in the air, uniformly spraying a layer of ninhydrin solution on the silica gel G thin layer plate, and heating the silica gel G thin layer plate in a drying oven at the constant temperature of 105 ℃ until spots are clearly developed; observing the color and the quantity of main spots at the positions where the spots appear in the chromatogram of the test solution, wherein the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the pork liver reference medicinal material, and four red spots also appear at the corresponding positions in the chromatogram of the reference solution, wherein the positions of the four red spots are valine, alanine, glycine and citrulline from top to bottom in sequence, and when the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the test solution, the to-be-tested sample can be determined to be the liver extract. When the spots are weak and difficult to distinguish, the color can be deepened after the product is placed for 1 day and observed.
In order to further implement the present invention, the following technical solutions may be preferably selected:
preferably, the n-butanol-glacial acetic acid-water is n-butanol, and the glacial acetic acid and the water are prepared according to the volume ratio of 6-8:2-3: 1.
Preferably, the ninhydrin solution is prepared by diluting 1-2g of ninhydrin with ethanol to 100 ml.
Preferably, the drying temperature of the fresh pork liver is not higher than 60 ℃, and the water content after drying is not more than 5%.
Through the technical scheme, the invention has the beneficial effects that:
the method has strong specificity, can detect the specific components in the liver essence paste, has good reproducibility, short detection time, high speed, intuition, simple and convenient steps, simple instrument and low detection cost. The main components of the pork liver after extraction, concentration and refining are amino acid or polypeptides, vitamins and minerals. The thin-layer map of amino acid components has specificity, and the combination of color depth, number and position of each spot is unique and different from other substances. The liver essence cream contains at least four amino acid components of valine, alanine, glycine, citrulline and the like, has a certain proportion relation, and can be identified by taking the four amino acid components as the characteristics. The pork liver powder prepared from the fresh pork liver is used as a reference medicinal material to replace a fresh pork liver reference medicinal material as a standard substance, the map of the pork liver powder is consistent with that of the fresh pork liver, the pork liver powder can be stored for a long time, the use is convenient, and the feasibility of the method is greatly improved.
Drawings
FIG. 1 is a chromatogram of a liver extract sample of the present invention and a citrulline and glycine control solution;
FIG. 2 is a chromatogram of a sample of liver extract of the present invention and a control solution of alanine and valine;
FIG. 3 is a chromatogram of a liver extract sample and a pork liver control solution of the present invention;
FIG. 4 is a comparison chromatogram of a pork liver control solution prepared from a pork liver paste sample and fresh pork liver and a pork liver powder sample of the present invention;
FIG. 5 is a chromatogram of a sample of liver essence cream of the present invention and a reference solution of citrulline, glycine, alanine, and valine;
FIG. 6 is one of chromatograms of the porcine liver control drug solution and valine, alanine, glycine and citrulline control solution of the present invention;
FIG. 7 is a second chromatogram of the control solution of pork liver of the present invention and the control solution of valine, alanine, glycine and citrulline;
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
a method for identifying the authenticity of liver essence paste based on thin-layer chromatography comprises the following specific steps:
preparation of a test solution: taking 1g of a sample to be detected, adding 20ml of ethanol, carrying out ultrasonic treatment for 30min, and then filtering, wherein the filtered filtrate is used as a sample solution;
preparing a pork liver reference medicinal material solution: drying fresh pork liver at low temperature, pulverizing to obtain pork liver powder, adding 1g pork liver powder, adding 4ml water, adding 1 drop of 2% hydrochloric acid, shaking, keeping the temperature at 100 deg.C for 40min, centrifuging, collecting supernatant, concentrating to near dryness, adding 4ml ethanol to dissolve, centrifuging again, and collecting supernatant as pork liver control medicinal material solution;
preparation of control solutions: respectively taking valine, alanine, glycine and citrulline reference substances, and adding methanol to obtain solutions each containing 0.5mg per 1ml as reference substance solutions;
and (3) detection by thin-layer chromatography: sucking 2-4 mul of a test solution, 2-4 mul of a pork liver control medicinal material solution and 2 mul of a control solution respectively, respectively dropping the solutions on the same silica gel G thin layer plate, developing by using n-butyl alcohol-glacial acetic acid-water as a developing agent, taking out the silica gel G thin layer plate, drying in the air, uniformly spraying a layer of ninhydrin solution on the silica gel G thin layer plate, and heating the silica gel G thin layer plate in a drying oven at the constant temperature of 105 ℃ until spots are clearly developed; observing the color and the quantity of main spots at the positions where the spots appear in the chromatogram of the test solution, wherein the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the pork liver reference medicinal material, and four red spots also appear at the corresponding positions in the chromatogram of the reference solution, wherein the positions of the four red spots are valine, alanine, glycine and citrulline from top to bottom in sequence, and when the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the test solution, the to-be-tested sample can be determined to be the liver extract. When the spots are weak and difficult to distinguish, the color can be deepened after the product is placed for 1 day and observed.
In the embodiment, the n-butanol-glacial acetic acid-water is n-butanol, glacial acetic acid and water are prepared according to the volume ratio of 8:3:1, and the ninhydrin test solution is prepared by diluting 2g of ninhydrin with ethanol to 100 ml.
In order to ensure the identification accuracy, the drying temperature of the fresh pork liver is not higher than 60 ℃, and the moisture content after drying is not more than 5%.
Example 2:
a method for identifying the authenticity of liver essence paste based on thin-layer chromatography comprises the following specific steps:
preparation of a test solution: taking 1g of a sample to be detected, adding 20ml of ethanol, carrying out ultrasonic treatment for 30min, and then filtering, wherein the filtered filtrate is used as a sample solution;
preparing a pork liver reference medicinal material solution: mashing fresh pork liver, weighing 2-3g, adding 4ml of water, adding 1 drop of 2% hydrochloric acid, shaking, keeping the temperature at 90 ℃ for 40min, centrifuging, collecting supernatant, concentrating to near dryness, adding 4ml of ethanol for dissolving, centrifuging again, and collecting supernatant as pork liver control solution;
preparation of control solutions: respectively taking valine, alanine, glycine and citrulline reference substances, and adding methanol to obtain solutions each containing 0.5mg per 1ml as reference substance solutions;
and (3) detection by thin-layer chromatography: sucking 2-4 mul of a test solution, 2-4 mul of a pork liver control medicinal material solution and 2 mul of a control solution respectively, respectively dropping the solutions on the same silica gel G thin layer plate, developing by using n-butyl alcohol-glacial acetic acid-water as a developing agent, taking out the silica gel G thin layer plate, drying in the air, uniformly spraying a layer of ninhydrin solution on the silica gel G thin layer plate, and heating the silica gel G thin layer plate in a drying oven at the constant temperature of 105 ℃ until spots are clearly developed; observing the color and the quantity of main spots at the positions where the spots appear in the chromatogram of the test solution, wherein the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the pork liver reference medicinal material, and four red spots also appear at the corresponding positions in the chromatogram of the reference solution, wherein the positions of the four red spots are valine, alanine, glycine and citrulline from top to bottom in sequence, and when the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the test solution, the to-be-tested sample can be determined to be the liver extract. When the spots are weak and difficult to distinguish, the color can be deepened after the product is placed for 1 day and observed.
In the embodiment, the n-butanol-glacial acetic acid-water is n-butanol, glacial acetic acid and water are prepared according to the volume ratio of 6:2:1, and the preparation method of the ninhydrin test solution is to dilute 2g of ninhydrin to 100 ml.
As shown in fig. 1, the liver extract sample has spots with the same color as citrulline and glycine, which indicates that the liver extract can contain the above components, and the liver extract can be identified.
As shown in fig. 2, the same color spots of the liver extract sample as alanine and valine showed that the liver extract can contain the above components, and the liver extract can be identified. The corresponding spots of arginine are not obvious and the positions are too low, which is not used as a judgment basis.
As shown in fig. 3 and 4, the liver essence cream sample and the pork liver control solution have the same color spots, which indicates that the liver essence cream can contain the above components, and the liver essence cream can be identified by the same; the deployment conditions of fig. 3 and 4 are slightly different. The fresh pork liver has the same atlas with pork liver powder, which shows that the pork liver powder can replace the fresh pork liver as a reference medicine. The pork liver powder prepared from the fresh pork liver is used as a reference medicinal material to replace a fresh pork liver reference medicinal material to be used as a standard substance, can be stored for a long time, is convenient to use, and greatly improves the feasibility and the practicability of the method.
As shown in fig. 5, the same color spots of the liver extract samples as valine, alanine, glycine and citrulline indicate that the liver extract can contain the above components, and the liver extract can be identified.
As shown in fig. 6 and 7, the pork liver control solution and the valine, alanine, glycine and citrulline control solution have the same color spots, and no other spots are generated in the mixed sample, which indicates that the above components can be contained in the liver extract, and the liver extract can be identified; FIG. 7 is a graph of FIG. 6 after 1 day of storage, and it was found that the spots were more visible, the glycine spots were not visible in FIG. 6 but were barely visible, and the glycine spots were more visible in FIG. 7.
The method has strong specificity, can detect the specific components in the liver essence paste, has good reproducibility, short detection time, high speed, intuition, simple and convenient steps, simple instrument and low detection cost. The main components of the pork liver after extraction, concentration and refining are amino acid or polypeptides, vitamins and minerals. The thin-layer map of amino acid components has specificity, and the combination of color depth, number and position of each spot is unique and different from other substances. The liver essence cream contains at least four amino acid components of valine, alanine, glycine, citrulline and the like, has a certain proportion relation, and can be identified by taking the four amino acid components as the characteristics. The pork liver powder prepared from the fresh pork liver is used as a reference medicinal material to replace a fresh pork liver reference medicinal material as a standard substance, the map of the pork liver powder is consistent with that of the fresh pork liver, the pork liver powder can be stored for a long time, the use is convenient, and the feasibility of the method is greatly improved.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments or portions thereof without departing from the spirit and scope of the invention.
Claims (4)
1. A method for identifying the authenticity of liver essence paste based on thin-layer chromatography is characterized by comprising the following specific steps:
preparation of a test solution: taking 1g of a sample to be detected, adding 20ml of ethanol, carrying out ultrasonic treatment for 30min, and then filtering, wherein the filtered filtrate is used as a sample solution;
preparing a pork liver reference medicinal material solution: drying fresh pork liver at low temperature, pulverizing to obtain pork liver powder, adding 1g pork liver powder, adding 4ml water, adding 1 drop of 2% hydrochloric acid, shaking, keeping the temperature at 90-100 deg.C for 40min, centrifuging, collecting supernatant, concentrating to near dryness, adding 4ml ethanol for dissolving, centrifuging again, and collecting supernatant as pork liver control medicinal material solution;
preparation of control solutions: respectively taking valine, alanine, glycine and citrulline reference substances, and adding methanol to obtain solutions each containing 0.5mg per 1ml as reference substance solutions;
and (3) detection by thin-layer chromatography: sucking 2-4 mul of a test solution, 2-4 mul of a pork liver control medicinal material solution and 2 mul of a control solution respectively, respectively dropping the solutions on the same silica gel G thin layer plate, developing by using n-butyl alcohol-glacial acetic acid-water as a developing agent, taking out the silica gel G thin layer plate, drying in the air, uniformly spraying a layer of ninhydrin solution on the silica gel G thin layer plate, and heating the silica gel G thin layer plate in a drying oven at the constant temperature of 105 ℃ until spots are clearly developed; observing the color and the quantity of main spots at the positions where the spots appear in the chromatogram of the test solution, wherein the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the pork liver reference medicinal material, and four red spots also appear at the corresponding positions in the chromatogram of the reference solution, wherein the positions of the four red spots are valine, alanine, glycine and citrulline from top to bottom in sequence, and when the spots with the same color and quantity appear at the corresponding positions in the chromatogram of the test solution, the to-be-tested sample can be determined to be the liver extract. When the spots are weak and difficult to distinguish, the color can be deepened after the product is placed for 1 day and observed.
2. The method for identifying the authenticity of the liver extract based on the thin-layer chromatography as claimed in claim 1, wherein the n-butanol-glacial acetic acid-water is n-butanol, and the glacial acetic acid and the water are prepared according to a volume ratio of 6-8:2-3: 1.
3. The method for identifying the authenticity of the liver extract based on the thin layer chromatography as claimed in claim 1, wherein the ninhydrin solution is prepared by diluting 1-2g of ninhydrin with ethanol to 100 ml.
4. The method for identifying the authenticity of the liver extract based on the thin layer chromatography as claimed in claim 1, wherein the drying temperature of the fresh pork liver is not higher than 60 ℃, and the moisture content after drying is not more than 5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111560555.8A CN114324724A (en) | 2021-12-20 | 2021-12-20 | Method for identifying authenticity of liver essence paste based on thin-layer chromatography |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111560555.8A CN114324724A (en) | 2021-12-20 | 2021-12-20 | Method for identifying authenticity of liver essence paste based on thin-layer chromatography |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114324724A true CN114324724A (en) | 2022-04-12 |
Family
ID=81053327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111560555.8A Pending CN114324724A (en) | 2021-12-20 | 2021-12-20 | Method for identifying authenticity of liver essence paste based on thin-layer chromatography |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114324724A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552751A (en) * | 2010-12-29 | 2012-07-11 | 江西济民可信集团有限公司 | Quality detection method for medicine (named as Er bao concentrated decoction) |
| CN102707011A (en) * | 2012-07-02 | 2012-10-03 | 涂瑶生 | Thin-layer chromatography identification method of white gourd kernel formula granules |
| CN103808842A (en) * | 2014-01-17 | 2014-05-21 | 黑龙江葵花药业股份有限公司 | Quality detection method for liver protection dropping pill of traditional Chinese medicine preparation |
| CN107677760A (en) * | 2017-11-01 | 2018-02-09 | 广西壮族自治区食品药品检验所 | The TLC Identification of goat's horn |
| CN107976509A (en) * | 2017-11-01 | 2018-05-01 | 广西壮族自治区食品药品检验所 | The TLC Identification of husky ox |
| WO2021073175A1 (en) * | 2019-10-16 | 2021-04-22 | 石家庄以岭药业股份有限公司 | Method for identifying various ingredients in traditional chinese medicine composition and measuring contents |
-
2021
- 2021-12-20 CN CN202111560555.8A patent/CN114324724A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552751A (en) * | 2010-12-29 | 2012-07-11 | 江西济民可信集团有限公司 | Quality detection method for medicine (named as Er bao concentrated decoction) |
| CN102707011A (en) * | 2012-07-02 | 2012-10-03 | 涂瑶生 | Thin-layer chromatography identification method of white gourd kernel formula granules |
| CN103808842A (en) * | 2014-01-17 | 2014-05-21 | 黑龙江葵花药业股份有限公司 | Quality detection method for liver protection dropping pill of traditional Chinese medicine preparation |
| CN107677760A (en) * | 2017-11-01 | 2018-02-09 | 广西壮族自治区食品药品检验所 | The TLC Identification of goat's horn |
| CN107976509A (en) * | 2017-11-01 | 2018-05-01 | 广西壮族自治区食品药品检验所 | The TLC Identification of husky ox |
| WO2021073175A1 (en) * | 2019-10-16 | 2021-04-22 | 石家庄以岭药业股份有限公司 | Method for identifying various ingredients in traditional chinese medicine composition and measuring contents |
Non-Patent Citations (2)
| Title |
|---|
| 张建英;刘惠军;张艳慧;张少杰;: "珍珠层粉胶囊中氨基酸的薄层色谱鉴别", 中国医药指南, no. 29, pages 49 - 51 * |
| 邓丽娟;刘睿婷;胡小霞;黄琼;李新霞;: "大蒜粉薄层色谱鉴别方法的建立", 中国民族民间医药, no. 19 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Nutritional compositions of Indian Moringa oleifera seed and antioxidant activity of its polypeptides | |
| DAUGHADAY et al. | Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum | |
| Berg | [17] Determination of 3-and 4-hydroxyproline | |
| Wolkoff et al. | Hepatic accumulation and intracellular binding of conjugated bilirubin | |
| CN104274338A (en) | Proteoglycan-containing material | |
| CN103018452A (en) | Salbutamol drug detection colloidal gold test paper card and detection method | |
| CN113176362B (en) | Method for evaluating allergenicity of natural bee pollen and fermented bee pollen | |
| CN114778736B (en) | Identification method of trace pilose antler polypeptide in Naoling preparation and application thereof | |
| CN108828108A (en) | The method of many animals derived component in product containing gelatin crude drug is detected simultaneously | |
| CS566490A3 (en) | Determination of appendicitis by determining concentration of delta hydroxyhippuric acid in urine | |
| Mason | The quantitative importance of bacterial residues in the non‐dietary faecal nitrogen of sheep: I. Methodology studies | |
| CN114324724A (en) | Method for identifying authenticity of liver essence paste based on thin-layer chromatography | |
| Richardson et al. | Application of a commercial radioassay test kit to the determination of vitamin B12 in food | |
| CN101498726B (en) | Colloidal gold test paper card for detecting enrofloxacin medicament residue | |
| Hedbom | A native cobalamin–polypeptide complex from liver: isolation and characterization | |
| CN110018269B (en) | Thin-layer identification method for salt flatstem milkvetch seed formula granules | |
| Jowett | The estimation of vitamin B1 in urine | |
| CN112946129A (en) | Quality detection method of antidiarrheal syrup | |
| CN113009050A (en) | Detection method and application of quinolone compounds in dairy products | |
| CN107677760B (en) | Thin-layer chromatography identification method for sheep horn | |
| CN104792920A (en) | Reverse-phase thin-layer chromatography identification method for bile acid components in livestock bile powder | |
| CN114137194B (en) | Blood-replenishing effect-based angelica quality evaluation method | |
| CN114324647B (en) | Simultaneous determination of vitamin K in milk powder 1 And K 2 Methods and uses of (2) | |
| Howarth et al. | Bloat Investigations: Determination of Soluble Protein Concentration in Alfalfa 1 | |
| CN115032308A (en) | Method for constructing and identifying characteristic spectrum of medulla Tetrapanacis medicinal material, decoction pieces, standard decoction, dry extract powder and traditional Chinese medicine formula granules thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |